Related references
Note: Only part of the references are listed.Proteasomal and Genetic Inactivation of the NF1 Tumor Suppressor in Gliomagenesis
Lauren T. McGillicuddy et al.
CANCER CELL (2009)
Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1
David A. Barbie et al.
NATURE (2009)
Genome-Wide Profiling of Histone H3 Lysine 4 and Lysine 27 Trimethylation Reveals an Epigenetic Signature in Prostate Carcinogenesis
Xi-Song Ke et al.
PLOS ONE (2009)
Microenvironmental regulation of metastasis
Johanna A. Joyce et al.
NATURE REVIEWS CANCER (2009)
Cancer statistics, 2008
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2008)
Shared principles in NF-κB signaling
Matthew S. Hayden et al.
CELL (2008)
NF-κB and cancer -: identifying targets and mechanisms
Willscott E. Naugler et al.
CURRENT OPINION IN GENETICS & DEVELOPMENT (2008)
Roles of the EZH2 histone methyltransferase in cancer epigenetics
Jeffrey A. Simon et al.
MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS (2008)
Somatic mutations affect key pathways in lung adenocarcinoma
Li Ding et al.
NATURE (2008)
Comprehensive genomic characterization defines human glioblastoma genes and core pathways
L. Chin et al.
NATURE (2008)
Gene silencing in cancer by histone H3 lysine 27 trimethylation independent of promoter DNA methylation
Yutaka Kondo et al.
NATURE GENETICS (2008)
BRAF Activation Initiates but Does Not Maintain Invasive Prostate Adenocarcinoma
Joseph H. Jeong et al.
PLOS ONE (2008)
Adaptation versus selection: The origins of metastatic behavior
Christina Scheel et al.
CANCER RESEARCH (2007)
A polycomb repression signature in metastatic prostate cancer predicts cancer outcome
Jindan Yu et al.
CANCER RESEARCH (2007)
Pten inactivation and the emergence of androgen-independent prostate cancer
Michael M. Shen et al.
CANCER RESEARCH (2007)
BRAF and KRAS mutations in prostatic adenocarcinoma
Nam-Yun Cho et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
Recent progress in hormonal therapy for advanced prostate cancer
Timothy J. Daskivich et al.
CURRENT OPINION IN UROLOGY (2006)
The NF1 tumor suppressor critically regulates TSC2 and mTOR
CM Johannessen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Down-regulation of human DAB2IP gene expression mediated by polycomb Ezh2 complex and histone deacetylase in prostate cancer
H Chen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Aberrant promoter methylation in human DAB2 interactive protein (hDAB2IP) gene in gastrointestinal tumour
H Dote et al.
BRITISH JOURNAL OF CANCER (2005)
Aberrant promoter methylation of human DAB2 interactive protein (hDAB2IP) gene in lung cancers
M Yano et al.
INTERNATIONAL JOURNAL OF CANCER (2005)
Identification of a novel RAS GTPase-activating protein (RASGAP) gene at 9q34 as an MLL fusion partner in a patient with de novo acute myeloid leukemia
ARM von Bergh et al.
GENES CHROMOSOMES & CANCER (2004)
Aberrant promoter methylation in human DAB2 interactive protein (hDAB2IP) gene in breast cancer
H Dote et al.
CLINICAL CANCER RESEARCH (2004)
Gene expression profiling identifies clinically relevant subtypes of prostate cancer
J Lapointe et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Androgen-induced differentiation and tumorigenicity of human prostate epithelial cells
R Berger et al.
CANCER RESEARCH (2004)
Epithelial-mesenchymal transition -: NF-κB takes center stage
MA Huber et al.
CELL CYCLE (2004)
Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis
J Yang et al.
CELL (2004)
AIP1/DAB2IP, a novel member of the Ras-GAP family, transduces TRAF2-induced ASK1-JNK activation
HF Zhang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Prostate-specific deletion of the murine Pten tumor suppressor gene leads to metastatic prostate cancer
SY Wang et al.
CANCER CELL (2003)
Mechanisms of disease: Prostate cancer
WG Nelson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Epigenetic regulation of a novel tumor suppressor gene (hDAB2IP) in prostate cancer cell lines
H Chen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
The polycomb group protein EZH2 is involved in progression of prostate cancer
S Varambally et al.
NATURE (2002)
Epithelial-mesenchymal transitions in tumour progression
JP Thiery
NATURE REVIEWS CANCER (2002)
Gene expression analysis of prostate cancers
JH Luo et al.
MOLECULAR CARCINOGENESIS (2002)
Prognosis of cancers associated with venous thromboembolism.
HT Sorensen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Ral GTPases contribute to regulation of cyclin D1 through activation of NF-κB
DO Henry et al.
MOLECULAR AND CELLULAR BIOLOGY (2000)
Share Paper
